The Emotional Impact of Surveillance for Pancreatic Cancer

Integrated University Hospital Trust of Verona

Status: Unknown

Conditions: Psychological Distress; Pancreatic Cancer

Treatments: Diagnostic Test: General Self-Efficacy Scale (GSES); Diagnostic Test: Multidimensional Scale of Perceived Social Support (MSPSS); Diagnostic Test: Global Assessment of Functioning scale (GAF); Diagnostic Test: Barratt Simplified Measure of Social Status (BSMSS); Diagnostic Test: Coping Orientation to Problems Experienced (Brief COPE),; Diagnostic Test: Perceived Stress Scale (PSS)

Study type: Interventional

Funder types: Other

Identifiers

NCT04024345

Psy-FPC

Details and patient eligibility

About

Due to its rarity a population screening program for pancreatic cancer is not possible. For this reason, considering background data on genetic predisposition and familiarity for this lethal tumor, efforts have been pushed to build up surveillance programs for subjects at high-risk of pancreatic cancer, due to familiarity and/or genetic predisposition. These programs are based on radiological examinations (such as MRI or endoultrasonography) and laboratory tests. However, little is known about the psychological burden of these programs. Only a handful of studies investigated, in various ways, how the participation in surveillance programs for pancreatic cancer may burden the psychological status, with a consequent possible impairment of the psychological wellbeing, and a higher risk of withdraw from the surveillance program itself. The aim of this study was to assess the psychological and emotional impact in high-risk individuals participating in a surveillance program for pancreatic cancer due to familiarity and/or to genetic predisposition, using specific psychological tools, such as multiple psychological questionnaires, investigating different functioning areas, administered by a clinical psychologist.

Enrollment: 150 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Being enrolled in the Institutional surveillance program for pancreatic cancer
• Ability to understand the details and implications of a study protocol.

Exclusion criteria

• None

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

150 participants in 1 patient group

Psychometric assessment group

Experimental group

Description:

Arms to whom the psychometric assessment will be administered

Treatment:

Diagnostic Test: Multidimensional Scale of Perceived Social Support (MSPSS)

Diagnostic Test: Barratt Simplified Measure of Social Status (BSMSS)

Diagnostic Test: Coping Orientation to Problems Experienced (Brief COPE),

Diagnostic Test: Perceived Stress Scale (PSS)

Diagnostic Test: Global Assessment of Functioning scale (GAF)

Diagnostic Test: General Self-Efficacy Scale (GSES)